What can go wrong with a SPAC? More than you can imagine, says CFO

The vehicle that an increasing number of companies are using to go public, called a special purpose acquisition company (SPAC), is billed on Wall Street as a streamlined way to list and attract investors. It's a chief reason the number of IPOs surged to 480 last year from 233 in 2019, according to Securities and Exchange Commission (SEC) data. 

But now that Ozan Pamir, CFO of biotechnology company 180 Life Sciences, has been through the process, he has some words of caution to anyone considering taking the same approach.  READ MORE